Cantor Fitzgerald Reaffirms “Overweight” Rating for DocGo (NASDAQ:DCGO)

DocGo (NASDAQ:DCGO)‘s stock had its “overweight” rating reaffirmed by equities researchers at Cantor Fitzgerald in a report released on Tuesday,Benzinga reports. They presently have a $3.00 target price on the stock. Cantor Fitzgerald’s target price would indicate a potential upside of 336.49% from the company’s previous close.

Several other equities research analysts have also issued reports on the stock. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of DocGo in a report on Monday, December 29th. Needham & Company LLC reissued a “buy” rating and issued a $3.00 price objective on shares of DocGo in a research note on Tuesday. Three equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, DocGo has an average rating of “Hold” and an average target price of $2.50.

DocGo Stock Down 11.6%

DocGo stock opened at $0.69 on Tuesday. DocGo has a 12-month low of $0.60 and a 12-month high of $2.86. The business’s 50-day moving average price is $0.76 and its two-hundred day moving average price is $1.02. The stock has a market cap of $67.22 million, a PE ratio of -0.37 and a beta of 0.95.

Hedge Funds Weigh In On DocGo

A number of hedge funds have recently modified their holdings of DCGO. Neuberger Berman Group LLC bought a new stake in shares of DocGo in the fourth quarter worth $29,000. Cerity Partners LLC bought a new position in DocGo during the 2nd quarter worth $37,000. Public Employees Retirement System of Ohio bought a new position in DocGo during the 4th quarter worth $40,000. Engineers Gate Manager LP acquired a new position in DocGo during the 2nd quarter worth about $52,000. Finally, Royce & Associates LP acquired a new position in DocGo during the 3rd quarter worth about $64,000. Institutional investors and hedge funds own 56.44% of the company’s stock.

More DocGo News

Here are the key news stories impacting DocGo this week:

• Positive Sentiment: Q4 results beat expectations and the company raised guidance, which previously sparked a ~15% share surge; this underpins the bullish case on near-term revenue momentum. Investing.com: DocGo shares surge on Q4 revenue beat Yahoo Finance: Q4 highlights
• Positive Sentiment: DocGo laid out 2026 revenue guidance of $290M–$310M and reiterated a push toward profitability while exploring strategic alternatives—moves investors may view as constructive for scaling and value realization. Seeking Alpha: DocGo outlines 2026 guidance
• Positive Sentiment: DocGo was named one of the 2026 World’s Most Ethical Companies® by Ethisphere — a reputational win that can support long-term customer and partner confidence. Business Wire: Ethisphere recognition
• Positive Sentiment: Two sell-side firms reaffirmed upbeat ratings: Cantor Fitzgerald maintained an “overweight” rating with a $3.00 target and Needham reaffirmed “buy” with a $3.00 target — both imply large upside from current levels. Benzinga: Cantor & Needham reaffirm
• Neutral Sentiment: Full earnings-call transcripts and recaps are available for deeper detail on margins, cadence and guidance assumptions; these will inform investor views but are informational rather than immediately price-moving on their own. MSN: Q4 earnings call transcript Seeking Alpha: Q4 transcript
• Negative Sentiment: Stifel Nicolaus cut its price target from $4.00 to $2.50 (though it kept a “buy” rating). The PT downgrade reduces some upside expectations and may have contributed to selling pressure. Benzinga: Stifel lowers price target

About DocGo

DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.

In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.